KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862,359 | -63.8% | 5,100 | -53.6% | 0.00% | -71.4% |
| Q2 2023 | $2,385,350 | -34.2% | 11,000 | -44.9% | 0.01% | -12.5% |
| Q1 2023 | $3,625,898 | -44.7% | 19,962 | -40.2% | 0.01% | -57.9% |
| Q4 2022 | $6,557,402 | -11.8% | 33,371 | +0.9% | 0.02% | -17.4% |
| Q3 2022 | $7,436,000 | +7.4% | 33,058 | -39.6% | 0.02% | 0.0% |
| Q2 2022 | $6,924,000 | +212.7% | 54,723 | +213.4% | 0.02% | +228.6% |
| Q1 2022 | $2,214,000 | +106.0% | 17,459 | +112.9% | 0.01% | +133.3% |
| Q4 2021 | $1,075,000 | +326.6% | 8,200 | +290.5% | 0.00% | +200.0% |
| Q1 2021 | $252,000 | -82.3% | 2,100 | -85.0% | 0.00% | -83.3% |
| Q4 2020 | $1,423,000 | +611.5% | 14,000 | +677.8% | 0.01% | +500.0% |
| Q2 2020 | $200,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |